Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-21-012906

President sold 15,000 shares at an average $62.29 ($934,365)

  • President acquired 15,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
RUBINSTEIN JULIE President 2021-02-19 Option exercise +15,000 $6.55 $98,250 15,000 D
RUBINSTEIN JULIE President 2021-02-19 Sale −3,499 $61.47 $215,084 11,501 D
RUBINSTEIN JULIE President 2021-02-19 Sale −7,708 $62.30 $480,208 3,793 D
RUBINSTEIN JULIE President 2021-02-19 Sale −3,793 $63.03 $239,073 0 D
Derivatives
RUBINSTEIN JULIE President 2021-02-19 Option exercise · Stock Option (Right to Buy) −15,000 285,000 D
Open-market sales · 15,000 sh · avg $62.29 · $934,365
Loading xslF345X03/doc4.xml…